Research has been very varied , however , daily consumption of green tea with doses of EGCG between 100 and 460 mg/day has shown greater effectiveness on body fat and body weight reduction in intervention periods of 12 weeks or more .
In addition , the use of caffeine doses between 80 and 300 mg/day has been shown to be an important factor for this effects , when the participants did not have a high caffeine intake ( > 300 mg/day ) prior to the intervention
The prevalence and incidence of overweight and obesity worldwide continues to increase , as well as diseases related to these conditions .
This is attributed to an increase in energy intake and a decrease in energy expenditure .
Consumption of green tea has been linked to a reduction in body fat and body weight .
However , research on green tea has been very diverse .
This review assesses the investigations that have been made with green tea and its epigallocatechin gallato ( EGCG ) content , evaluating its effect on body fat and body weight in humans .
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
BACKGROUND Current interest in the role of functional foods in weight control has focused on plant ingredients capable of interfering with the sympathoadrenal system . OBJECTIVE We investigated whether a green tea extract , by virtue of its high content of caffeine and catechin polyphenols , could increase 24-h energy expenditure ( EE ) and fat oxidation in humans . DESIGN Twenty-four-hour EE , the respiratory quotient ( RQ ) , and the urinary excretion of nitrogen and catecholamines were measured in a respiratory chamber in 10 healthy men . On 3 separate occasions , subjects were r and omly assigned among 3 treatments : green tea extract ( 50 mg caffeine and 90 mg epigallocatechin gallate ) , caffeine ( 50 mg ) , and placebo , which they ingested at breakfast , lunch , and dinner . RESULTS Relative to placebo , treatment with the green tea extract result ed in a significant increase in 24-h EE ( 4 % ; P < 0.01 ) and a significant decrease in 24-h RQ ( from 0.88 to 0.85 ; P < 0.001 ) without any change in urinary nitrogen . Twenty-four-hour urinary norepinephrine excretion was higher during treatment with the green tea extract than with the placebo ( 40 % , P < 0.05 ) . Treatment with caffeine in amounts equivalent to those found in the green tea extract had no effect on EE and RQ nor on urinary nitrogen or catecholamines . CONCLUSIONS Green tea has thermogenic properties and promotes fat oxidation beyond that explained by its caffeine content per se . The green tea extract may play a role in the control of body composition via sympathetic activation of thermogenesis , fat oxidation , or both
Research has been very varied , however , daily consumption of green tea with doses of EGCG between 100 and 460 mg/day has shown greater effectiveness on body fat and body weight reduction in intervention periods of 12 weeks or more .
In addition , the use of caffeine doses between 80 and 300 mg/day has been shown to be an important factor for this effects , when the participants did not have a high caffeine intake ( > 300 mg/day ) prior to the intervention
The prevalence and incidence of overweight and obesity worldwide continues to increase , as well as diseases related to these conditions .
This is attributed to an increase in energy intake and a decrease in energy expenditure .
Consumption of green tea has been linked to a reduction in body fat and body weight .
However , research on green tea has been very diverse .
This review assesses the investigations that have been made with green tea and its epigallocatechin gallato ( EGCG ) content , evaluating its effect on body fat and body weight in humans .